These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 22744939

  • 1. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
    Toral-Martiñón R, Shkurovich-Bialik P, Collado-Corona MA, Mora-Magaña I, Goldgrub-Listopad S, Shkurovich-Zaslavsky M.
    Arch Med Res; 2003 Mar; 34(3):205-8. PubMed ID: 14567400
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Mar; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K.
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [Abstract] [Full Text] [Related]

  • 8. [Ototoxicity of cisplatin in children with malignant diseases].
    Hadjilaskari P, Fengler R, Hartmann R, Henze G.
    Klin Padiatr; 1989 Sep; 201(4):316-21. PubMed ID: 2779137
    [Abstract] [Full Text] [Related]

  • 9. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 11. Ototoxic impact of cisplatin in pediatric oncology patients.
    Berg AL, Spitzer JB, Garvin JH.
    Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
    [Abstract] [Full Text] [Related]

  • 12. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
    Schlögel H, Stephan K, Böheim K, Welzl-Müller K.
    HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
    [Abstract] [Full Text] [Related]

  • 13. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM, Knief A, Lagosch AK, Deuster D, am Zehnhoff-Dinnesen A.
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [Abstract] [Full Text] [Related]

  • 14. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
    Weissenstein A, Deuster D, Knief A, Zehnhoff-Dinnesen AA, Schmidt CM.
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
    [Abstract] [Full Text] [Related]

  • 15. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Magy Onkol; 2006 Jan; 50(4):329-35. PubMed ID: 17216007
    [Abstract] [Full Text] [Related]

  • 16. [Hearing loss caused by high dose carboplatin therapy].
    Lautermann J, Adamczyk M, ten Cate WJ, Kloke O.
    Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
    [Abstract] [Full Text] [Related]

  • 17. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S.
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [Abstract] [Full Text] [Related]

  • 18. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M, Brandolini C, Ferri GG, Hatzopoulos S, Prete A, Pession A.
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [Abstract] [Full Text] [Related]

  • 19. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S, Del Valle Á, Chuang A, Becker A.
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen.
    Arora R, Thakur JS, Azad RK, Mohindroo NK, Sharma DR, Seam RK.
    Indian J Cancer; 2009 Aug; 46(4):311-7. PubMed ID: 19749461
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.